The Relationship Between Total Sialic Acid and Superoxide Dismutase and the Diagnosis and Prognosis of Lipoid Pneumonia
Launched by HU YINAN · May 21, 2024
Trial Information
Current as of February 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age≥ 18 years old;
- • 2. The diagnosis of lipoid pneumonia must be supported by lung biopsy pathological support or positive oil red O or Sudan staining in bronchoalveolar lavage fluid;
- • 3. Patients with bacterial and fungal pneumonia must be supported by etiological evidence;
- • 4. Patients with cryptogenic organizing pneumonia and pulmonary alveolar proteinosis must be supported by lung biopsy pathology;
- • 5. Patients with lung mucinous adenocarcinoma must be supported by lung tissue biopsy;
- • 6. Lung imaging of patients with pulmonary edema must show paving stone signs;
- Exclusion Criteria:
- • 1. Age\< 18 years old;
- • 2. The patient only has a history of lipid inhalation and no pathology or positive lipoid staining;
- • 3. Co-infection with the corona virus disease 2019 at the onset of illness;
- • 4. Pregnant
Trial Officials
Yinan Hu
Study Chair
China-Japan Friendship Hospital
About Hu Yinan
Hu Yinan is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on enhancing patient outcomes, the organization specializes in the design, implementation, and management of clinical trials across various therapeutic areas. Leveraging a robust network of healthcare professionals and cutting-edge technologies, Hu Yinan aims to facilitate efficient and ethical research practices. The sponsor is dedicated to fostering collaboration with stakeholders, ensuring compliance with regulatory standards, and prioritizing patient safety throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Beijing, Beijing, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0